(Circulation. 1997;96:1906-1913.)
© 1997 American Heart Association, Inc.
Articles |
From the Departments of Cardiovascular Biology (J.A., M.N., Y.T.), Surgery (J.D., M.M.), Internal Medicine (M.O., K.K.), and Physiology (N.T.), Faculty of Medicine, University of Tokyo, and the Department of Pathology, National Cancer Center East Hospital, Kashiwa, and Department of Laboratory Medicine (T.M.), Mitsui Memorial Hospital, Tokyo, Japan.
Correspondence to Yoh Takuwa, MD, Department of Cardiovascular Biology, Faculty of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.
Background Growth factors such as platelet-derived growth factor (PDGF) have been postulated to be important mediators of neointimal formation in balloon-injured artery. Binding of growth factors to their receptors activates intrinsic receptor tyrosine kinase, resulting in tyrosine phosphorylation of receptors themselves and cellular substrate proteins. We investigated in vivo activities of growth factors by determining the extent of tyrosine phosphorylation of growth factor receptors and substrate proteins in injured artery.
Methods and Results Rat balloon-injured carotid artery was
analyzed for phosphotyrosine content of PDGF
- and
ß-receptors, epidermal growth factor (EGF) receptors, and insulin
receptor substrate-1 (IRS-1) by immunoprecipitation and
anti-phosphotyrosine Western blot. The development of intimal
thickening after deendothelializing balloon
catheterization of rat carotid artery was accompanied
by transient twofold to threefold increases in the extent of tyrosyl
phosphorylation of PDGF
- and ß-receptors but not
EGF receptor or IRS-1. The AT1 angiotensin II
(Ang II) receptor antagonist TCV-116 markedly inhibited
both tyrosyl phosphorylation of PDGF
- and
ß-receptors and intimal thickening. The AT1
antagonist reduced mRNA levels of both PDGF-A and -B chains
in injured arteries.
Conclusions The present study provides direct evidence for increased PDGF activities in injured artery in situ and the involvement of Ang II in stimulated activation of PDGF receptors. These results are consistent with the pathogenetic role for PDGF in intimal thickening.
Key Words: stenosis growth substances balloon
This article has been cited by other articles:
![]() |
A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies Physiol Rev, July 1, 2008; 88(3): 887 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhuang, Q. Pu, B. Ceacareanu, Y. Chang, M. Dixit, and A. Hassid Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H163 - H173. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, C. Zhang, S. Schaefer, A. Estes, and K. U. Malik ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2592 - H2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, J. Zhang, G. Spinetti, L.-Q. Jiang, R. Monticone, D. Zhao, L. Cheng, M. Krawczyk, M. Talan, G. Pintus, et al. Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats Am. J. Pathol., November 1, 2005; 167(5): 1429 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bonello, Y. V. Bobryshev, and L. M. Khachigian Peroxide-Inducible Ets-1 Mediates Platelet-Derived Growth Factor Receptor-{alpha} Gene Transcription in Vascular Smooth Muscle Cells Am. J. Pathol., October 1, 2005; 167(4): 1149 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Konishi, T. Aizawa, A. Mohan, V. A. Korshunov, and B. C. Berk Hydrogen Peroxide Activates the Gas6-Axl Pathway in Vascular Smooth Muscle Cells J. Biol. Chem., July 2, 2004; 279(27): 28766 - 28770. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Usui, N. Sugimoto, N. Takuwa, S. Sakagami, S. Takata, S. Kaneko, and Y. Takuwa Blood Lipid Mediator Sphingosine 1-Phosphate Potently Stimulates Platelet-derived Growth Factor-A and -B Chain Expression through S1P1-Gi-Ras-MAPK-dependent Induction of Kruppel-like Factor 5 J. Biol. Chem., March 26, 2004; 279(13): 12300 - 12311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Brown and N. R. Kamal The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 339 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, Y. Izumi, Y. Izumiya, Y. Zhan, M. Taniguchi, and H. Iwao Beneficial Effects of Combined Blockade of ACE and AT1 Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Voisin, S. Foisy, E. Giasson, C. Lambert, P. Moreau, and S. Meloche EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors Am J Physiol Cell Physiol, August 1, 2002; 283(2): C446 - C455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhan, S. Kim, H. Yasumoto, M. Namba, H. Miyazaki, and H. Iwao Effects of Dominant-Negative c-Jun on Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 82 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries Circulation, November 6, 2001; 104(19): 2331 - 2337. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, Y. Zhan, Y. Izumi, H. Yasumoto, M. Yano, and H. Iwao In Vivo Activation of Rat Aortic Platelet-Derived Growth Factor and Epidermal Growth Factor Receptors by Angiotensin II and Hypertension Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2539 - 2545. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Leppanen, N. Janjic, M.-A. Carlsson, K. Pietras, M. Levin, C. Vargeese, L. S. Green, D. Bergqvist, A. Ostman, and C.-H. Heldin Intimal Hyperplasia Recurs After Removal of PDGF-AB and -BB Inhibition in the Rat Carotid Artery Injury Model Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20 (11): e89 - e95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MAYR, C. LI, Y. ZOU, U. HUEMER, Y. HU, and Q. XU Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases FASEB J, February 1, 2000; 14(2): 261 - 270. [Abstract] [Full Text] |
||||
![]() |
H. Iwasaki, S. Eguchi, H. Ueno, F. Marumo, and Y. Hirata Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H521 - H529. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-o Deguchi, M. Makuuchi, T. Nakaoka, T. Collins, and Y. Takuwa Angiotensin II Stimulates Platelet-Derived Growth Factor-B Chain Expression in Newborn Rat Vascular Smooth Muscle Cells and Neointimal Cells Through Ras, Extracellular Signal-Regulated Protein Kinase, and c-Jun N-Terminal Protein Kinase Mechanisms Circ. Res., October 1, 1999; 85(7): 565 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, Y. Zou, H. Dietrich, G. Wick, and Q. Xu Inhibition of Neointima Hyperplasia of Mouse Vein Grafts by Locally Applied Suramin Circulation, August 24, 1999; 100(8): 861 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bilder, T. Wentz, R. Leadley, D. Amin, L. Byan, B. O'Conner, S. Needle, H. Galczenski, J. Bostwick, C. Kasiewski, et al. Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A Circulation, June 29, 1999; 99(25): 3292 - 3299. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Brunner-La Rocca, G. Vaddadi, and M. D. Esler Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1163 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Giese, M. M. H. Marijianowski, O. McCook, A. Hancock, V. Ramakrishnan, L. J. Fretto, C. Chen, A. B. Kelly, J. A. Koziol, J. N. Wilcox, et al. The Role of Alpha and Beta Platelet-Derived Growth Factor Receptor in the Vascular Response to Injury in Nonhuman Primates Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 900 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tazawa, T. Nakane, and S. Chiba Angiotensin II Type 1 Receptor Blockade Prevents Up-Regulation of Angiotensin II Type 1A Receptors in Rat Injured Artery J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 898 - 904. [Abstract] [Full Text] |
||||
![]() |
J Abe, J Deguchi, Y Takuwa, K Hara, Y Ikari, T Tamura, M Ohno, and K Kurokawa Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris Heart, April 1, 1998; 79(4): 400 - 406. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |